How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

It's an upgrade worth making, but it comes down to your privacy concerns.

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

On Wednesday, OpenAI took its biggest step yet towards full technological independence with the unveiling of a new AI chip, ...

What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...

LinkDaddy® has expanded Cloud Authority Backlinks, a multi-cloud SEO system that delivers DoFollow backlinks, ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

The frontier model is a commodity. The companies winning are the ones that own distribution, and venture capital is paying up ...